Literature DB >> 4920400

Clinical experience with procarbazine in Hodgkin's disease, reticulum cell sarcoma, and lymphosarcoma.

D C Stolinsky, J Solomon, R P Pugh, A R Stevens, E M Jacobs, L E Irwin, D A Wood, J L Steinfeld, J R Bateman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4920400     DOI： 10.1002/1097-0142(197011)26:5<984::aid-cncr2820260504>3.0.co;2-e

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  4 in total

Review 1.  Antineoplastic drugs in 1990. A review (Part II).

Authors:  D J Black; R B Livingston
Journal:  Drugs       Date:  1990-05       Impact factor: 9.546

2.  Histiocytic medullary reticulosis in two Chinese women.

Authors:  R L Bick; T Adams
Journal:  West J Med       Date:  1974-02

Review 3.  Oral combination chemotherapy in the management of AIDS-related lymphoproliferative malignancies.

Authors:  S C Remick; N Sedransk; R Haase; M Craffey; N Subramanian; A Dowlati; T Nazeer; C Ramnes; C Blanchard; D Mastrianni; L Balducci; J Horton; J C Ruckdeschel
Journal:  Drugs       Date:  1999       Impact factor: 9.546

4.  Action of N-isopropyl-alpha-(2-methylhydrazino)-p-toluamide hydrochloride (procarbazine hydrochloride) in the germ tissue of mice: dominant lethal effects.

Authors:  G T Roberts; F M Johnson; H V Malling; R K Sharma
Journal:  Arch Toxicol       Date:  1979-02-23       Impact factor: 5.153
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.